Showing results (51-60 of 72) with videos related to

Sort By:
Pageof 8
Future Science OA|February 15, 2023
Telemedicine and cancer care in India: promises, opportunities and caveatsSuryanarayana Vs Deo, Raja Pramanik, Meesha Chaturvedi, et al.
The Indian Journal of Radiology & Imaging|December 1, 2022
Efficacy and Safety of Percutaneous Radiological Gastrostomy (PRG) as a Rescue Measure for Enteral Feeding in Patients with Advanced Head, Neck, and Upper Digestive MalignanciesMukesh Kumar, Anurag Chahal, Sundeep Malla, et al.
Annals of Surgical Oncology|October 3, 2021
Profile of Pathogenic Mutations and Evaluation of Germline Genetic Testing Criteria in Consecutive Breast Cancer Patients Treated at a North Indian Tertiary Care CenterAbhenil Mittal, S V S Deo, Ajay Gogia, et al.
Cancer Investigation|October 28, 2022
Real World Presentation and Treatment Outcomes with a Predominant Induction Chemotherapy Based Approach in Nasopharyngeal Carcinoma: A Sixteen Year Report from a Teaching Hospital in IndiaRamana Gogi, Aparna Sharma, Atul Sharma, et al.
JCO Global Oncology|February 22, 2024
SMART-ESAS: Smartphone Monitoring and Assessment in Real Time of Edmonton Symptom Assessment System Scores for Patients With CancerChitrakshi Nagpal, Atul Sharma, Sameer Bakhshi, et al.
Clinical Lung Cancer|November 21, 2025
Germline Variants in Indian Non-Small Cell Lung Cancer Patients With Familial Aggregation: A Prospective Cohort StudyAayushi Agrawal, Sindhura Durga Chitikela, Abhay Rastogi, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|May 6, 2024
Autologous Stem Cell Transplantation in Adult Hodgkin Lymphoma at a Tertiary Care Center in India: Analysis of Outcomes and Prognostic FactorsSudhir Kumar, Atul Sharma, Sameer Bakhshi, et al.
JCO Global Oncology|May 13, 2022
Long-Term Outcomes and Safety Trends of Autologous Stem-Cell Transplantation in Non-Hodgkin Lymphoma: A Report From A Tertiary Care Center in IndiaSudhir Kumar, Atul Sharma, Raja Pramanik, et al.
JCO Global Oncology|March 24, 2025
Olanzapine Versus NK1 Receptor Antagonist for Prevention of Carboplatin-Induced (AUC ≥4) Emesis: A Phase III, Double-Blind, Placebo-Controlled Randomized Trial From IndiaSneh Bhargave, Vinod Sharma, Babita Kataria, et al.
Ecancermedicalscience|March 5, 2024
Comprehensive germline profiling of patients with breast cancer: initial experience from a Familial Cancer ClinicRaja Pramanik, Sindhura Chitikela, S V S Deo, et al.
Pageof 8